The changing face of multiple sclerosis: Prevalence and incidence in an aging population

C Solaro1, M Ponzio2, E Moran3

  • 1Neurology Unit, Head and Neck Department, Azienda Sanitaria Locale 3 - ASL3, Genoa, Italy csolaro@libero.it.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|January 14, 2015
PubMed
Abstract

Insights

Multiple sclerosis (MS) prevalence increased in Genoa, Italy, with a higher incidence observed in older adults. This highlights the need for healthcare system adjustments to accommodate the growing elderly MS population and their unique medical requirements.

Area of Science:

  • Neurology
  • Epidemiology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease.
  • Understanding the epidemiological trends of MS is crucial for public health planning.

Purpose of the Study:

  • To determine the incidence and prevalence of multiple sclerosis (MS) in Genoa, Italy, between 1998 and 2007.
  • To analyze demographic data and identify trends in MS diagnosis and affected age groups.

Main Methods:

  • Retrospective analysis of MS cases diagnosed before December 31, 2007.
  • Data sources included hospital archives, the Italian MS society, general practitioner records, and cerebrospinal fluid (CSF) oligoclonal band analysis.

Main Results:

  • A total of 1312 MS patients were identified in Genoa.
  • The overall crude prevalence rate was 148.5/100,000, with higher rates in women (189.1/100,000) than men (103.1/100,000).
  • The mean annual incidence rate was 6.6/100,000, with a notable increase in individuals over 60.

Conclusions:

  • MS prevalence in Genoa has increased compared to previous years.
  • The mean age at diagnosis is relatively high (39 years), with a significant proportion of patients over 65.
  • Healthcare systems must adapt to the needs of an aging MS population, and medical professionals should be aware of the rising incidence in older adults.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
2
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.4K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
2
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
375
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
346
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
828